z-logo
open-access-imgOpen Access
Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
Author(s) -
Joan T. Garrett,
Anindita Chakrabarty,
Carlos L. Arteaga
Publication year - 2018
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.26017
Subject(s) - pi3k/akt/mtor pathway , medicine , cancer , cancer research , pharmacology , bioinformatics , oncology , chemistry , signal transduction , biology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom